• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主髂动脉周围血管疾病。

Aorto-iliac peripheral artery disease.

机构信息

Cardiovascular Section, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.

Cardiovascular Section, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America.

出版信息

Prog Cardiovasc Dis. 2021 Mar-Apr;65:9-14. doi: 10.1016/j.pcad.2021.02.010. Epub 2021 Feb 22.

DOI:10.1016/j.pcad.2021.02.010
PMID:33631164
Abstract

Aorto-iliac disease is a common manifestation of atherosclerosis. Individuals with this condition are at heightened cardiovascular risk, and may have limb symptoms ranging from claudication to limb-threatening ischemia. A regimen of medical therapy, risk factor modification, and exercise is first line therapy. Revascularization is reserved for individuals with lifestyle-limiting claudication despite conservative therapy and in those with chronic limb-threatening ischemia. Multiple endovascular therapies are now available that enable even the most complex aorto-iliac lesions to be approached and treated with safe and durable results.

摘要

主髂动脉疾病是动脉粥样硬化的常见表现。患有这种疾病的个体心血管风险增加,可能会出现从跛行到肢体威胁性缺血等症状。药物治疗、危险因素改变和运动是一线治疗方法。血管重建术保留给生活方式受限的跛行患者,即使是最复杂的主髂动脉病变也可以安全且持久地治疗。目前有多种血管内治疗方法,可用于治疗最复杂的主髂动脉病变。

相似文献

1
Aorto-iliac peripheral artery disease.主髂动脉周围血管疾病。
Prog Cardiovasc Dis. 2021 Mar-Apr;65:9-14. doi: 10.1016/j.pcad.2021.02.010. Epub 2021 Feb 22.
2
SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.SCAI关于主-髂动脉介入治疗合理应用的专家共识声明
Catheter Cardiovasc Interv. 2014 Oct 1;84(4):520-8. doi: 10.1002/ccd.25505. Epub 2014 May 28.
3
One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.主髂动脉病变血管内治疗的一年期疗效
Circ Cardiovasc Interv. 2019 Jan;12(1):e007441. doi: 10.1161/CIRCINTERVENTIONS.118.007441.
4
AFX unibody stent graft: Effective and safe for the treatment of severe aorto-iliac occlusive disease.AFX 一体化支架移植物:治疗严重的主髂动脉闭塞性疾病安全有效。
Vascular. 2024 Oct;32(5):1015-1025. doi: 10.1177/17085381231192686. Epub 2023 Jul 27.
5
SCAI guidelines on device selection in Aorto-Iliac arterial interventions.SCAI关于主-髂动脉介入治疗中器械选择的指南。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):915-929. doi: 10.1002/ccd.28947. Epub 2020 May 14.
6
Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease.个体患者数据的荟萃分析:吻式支架治疗主髂动脉闭塞性疾病后的结果。
J Endovasc Ther. 2019 Feb;26(1):31-40. doi: 10.1177/1526602818810535. Epub 2018 Nov 30.
7
Intervention of Prohibitive Aortic and Iliac Atherosclerotic Stenosis to Allow Successful Transfemoral Transcatheter Aortic Valve Replacement.介入治疗严重的主动脉和髂动脉粥样硬化狭窄以实现成功的经股动脉经导管主动脉瓣置换术
JACC Cardiovasc Interv. 2018 Sep 10;11(17):e137-e140. doi: 10.1016/j.jcin.2018.06.042. Epub 2018 Aug 15.
8
Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Circ Cardiovasc Interv. 2020 Aug;13(8):e009168. doi: 10.1161/CIRCINTERVENTIONS.120.009168. Epub 2020 Jul 29.
9
Endovascular revascularization for aortoiliac atherosclerotic disease.主动脉髂动脉粥样硬化疾病的血管内血运重建术。
Vasc Health Risk Manag. 2016 Mar 29;12:117-27. doi: 10.2147/VHRM.S98721. eCollection 2016.
10
Focal aorto-iliac atherosclerosis amenable to endovascular interventions though considered benign carry a significant risk of cardiovascular mortality: clinical investigation.尽管被认为是良性的,但适合血管内介入治疗的局灶性主-髂动脉粥样硬化存在心血管死亡的重大风险:临床研究。
Int Angiol. 2015 Feb;34(1):67-74. Epub 2014 May 13.

引用本文的文献

1
Early outcomes of drug-coated balloon angioplasty and stent placement for the treatment of iliac artery lesions.药物涂层球囊血管成形术和支架置入术治疗髂动脉病变的早期疗效。
Front Surg. 2025 Jul 3;12:1598354. doi: 10.3389/fsurg.2025.1598354. eCollection 2025.